Theremia

Paris, France

Theremia reduces side effects and increases medication efficacy for various patient groups.

$3.2M raised

Nov 2024

Seed

Top Investors

BpifranceEntrepreneurs FirstSalicaEurazeoBetter Angle

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Theremia raised?

Theremia has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in November 2024.

Who are Theremia's investors?

Theremia's investors include Bpifrance, Entrepreneurs First, Salica, Eurazeo, Better Angle.

Where is Theremia headquartered?

Theremia is headquartered in Paris, France.

What does Theremia do?

Theremia reduces side effects and increases medication efficacy for various patient groups.

What stage is Theremia at?

Theremia is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 7, 2024.

MLA

"Theremia — Funding & Investors." VCBacked, November 7, 2024, https://www.vcbacked.co/company/theremia. Accessed June 4, 2026.

APA

VCBacked. (2024). Theremia — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/theremia

Wikipedia (cite web)

{{cite web |title=Theremia — Funding & Investors |url=https://www.vcbacked.co/company/theremia |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 7, 2024.